Allergen exposure activates gasdermin D in lung epithelial cells through an iron-mediated, protease-independent mechanism requiring the PAR1-ferritinophagy-PCBP2 axis. This unconventional cleavage drives IL-33 release and allergic airway inflammation, highlighting intracellular iron as a promising therapeutic target for allergic diseases.